Lincoln Capital Corp Illumina, Inc. Transaction History

Lincoln Capital Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	BUY	$187.24 - $242.74 $187,240 - $242,740	1,000 New	1,000 $0
Q2 2022 Jul 22, 2022	SELL	$181.58 - $368.0 $127,106 - $257,600	-700 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$303.87 - $423.8 $212,709 - $296,660	700 New	700 $245,000
Q4 2021 Jan 24, 2022	SELL	$347.28 - $421.83 $173,640 - $210,915	-500 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$372.84 - $481.5 $186,420 - $240,750	500 New	500 $237,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Lincoln Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln Capital Corp with notifications on news.